Medical Use
Tepezza, an inhibitor of the insulin-like growth factor-1 receptor, is prescribed for treating Thyroid Eye Disease (TED), also referred to as Graves’ Orbitopathy.
Dosage Guidelines: The initial recommended dose of Tepezza is 10 mg per kg, administered via intravenous infusion. This is followed by 20 mg per kg infusions every three weeks for a total of seven additional doses. It is important to note that Tepezza should not be given as an intravenous push or bolus, nor should it be infused alongside other medications.
Warning & Precautions
Teprotumumab can lead to infusion reactions. If a patient experiences such a reaction, it is advisable to pre-medicate with an antipyretic, antihistamine, or corticosteroid, or to administer subsequent infusions at a slower rate.
The 500 mg dose of Teprotumumab may worsen preexisting inflammatory bowel disease (IBD). Patients with IBD should be monitored for disease flare-ups, and treatment should be discontinued if an exacerbation is suspected.
Teprotumumab treatment can also cause increased blood glucose levels or hyperglycemia. Patients should be monitored for elevated blood glucose and signs of hyperglycemia during therapy. Those with pre-existing diabetes should ensure proper glycemic control before starting treatment with Tepezza 500 mg injection.
Due to its mechanism of action on the insulin-like growth factor-1 receptor (IGF-1R), Tepezza may pose a risk to fetal health if administered during pregnancy. Women should inform their healthcare provider if they are pregnant or suspect they might be.
Documentation Availability
Documents required to import TEPEZZA to India?
TEPEZZA (teprotumumab-trbw) injection can be imported by patients or treating physicians on behalf of patients. The following documentation is required to import the product:
- (i)2 ID proofs along with PAN card details along with attested scanned copies
- (ii)Valid doctor prescription scanned copy
- (iii)Doctor’s MCI number
- (iv)Doctor’s mobile number
- (v)Patients diagnostic reports
How is the order confirmed?
The order will be confirmed only after the receipt of:
- (i)The above-mentioned documents and drug availability.
- (ii)Import permit if applicable.
Sourcing & Delivery
The Rx4U team has extensive experience in sourcing TEPEZZA (Cancer Treatment Medicines) from around the world, ensuring global access to the best available treatments for our customers. We are dedicated to promptly dispensing any valid prescription. All prescriptions are verified and dispatched directly to the patient’s address. Our patients are our top priority, and we strive to improve their lives through our services.
FAQ
What is the Generic Name for Tepezza®?
The generic name for Tepezza® is Teprotumumab.
Who Manufactures Tepezza®?
Tepezza® is produced by Horizon Therapeutics.
Is Tepezza® FDA Approved?
Yes, Tepezza® received FDA approval on January 21, 2020.
What is Tepezza®?
Tepezza® (teprotumumab-trbw) helps reduce eye bulging and double vision. It also alleviates symptoms of Thyroid Eye Disease, such as eye pain, redness, and swelling.
What is the Dosage and Form of Tepezza®?
Tepezza® is available as a 500 mg lyophilized powder in a single-dose vial, intended for reconstitution and intravenous administration.
How Much Does Teprotumumab Cost in India?
Teprotumumab is reasonably priced in India. For authentic procurement of this medication for Thyroid Eye Disease, you can visit the website https://rx4u.in/
What are the Common Side Effects of Tepezza®?
Common side effects of Tepezza® include dry skin, muscle spasms, diarrhea, nausea, hair loss, fatigue, high blood sugar, altered taste, hearing impairment, and headaches.
How Should Tepezza® be Stored?
Store Tepezza® 500 mg vials in the refrigerator at 2°C to 8°C (36°F to 46°F) in their original carton to protect from light. Do not freeze.
*Disclaimer
All Trademarks and Brands that appear on the website belong to their respective owners and Rx4U does not lay any claim on them we only provide Information.
